Teratology Literature and The Thalidomide Controversy
نویسنده
چکیده
The prospect of bearing an abnormal or deformed child has long been a chilling fear of all expectant mothers. Of the estimated 130 million children born each year worldwide, ] at least 2 to 3 percent are born with some type of birth defect.z It has only been within the last 150 years that doctors have attempted to interpret birth defects, or congenital malformations, in a scientific manner. The term “teratology” was first coined in 1832 by the French physician Isidore Geoffroy Saint-Hilaire to define a field of science dedicated to studying developmental anomalies. The term is derived from the Greek term ‘‘terato, ” meaning monster. He also described and classified the known abnormalities of his day. 3 While teratology had its origins in the descriptive anatomy of congenital malformations, Richard W. Smithells, Department of Pediatrics and Child Health, University of Leeds, UK, points out that today teratology includes any birth defect—morphological, biochemical, or behavioral-induced by an embryotoxic agent at any stage of gestation.’$This wider definition inevitably includes the involvement of many disciplines. For example, teratology is considered an offshoot of developmental biology. While developmental biology is the study of the overall development of the individual during gestation, teratology is primarily concerned with factors that interfere with developmental differentiation. These factors are often considered embryotoxins requiring the expertise of a toxicologist who December 15, 1986
منابع مشابه
New cases of thalidomide embryopathy in Brazil.
Thalidomide is the best known human teratogen. Although withdrawn from the market in 1961, thalidomide was remarketed after 1965 in several countries, for the treatment of erythema nodosum leprosum. Thalidomide has a potent immunomodulatory property and has now a number of approved and off-label uses in dermatologic, oncologic, infectious and gastrointestinal conditions. In the U.S., FDA approv...
متن کامل[Present status of behavioral teratology in Japan].
The thalidomide catastrophe in 1959-1962 has given great impetus to the basic research interests in the adverse effects of various insults on germ cells, embryos, fetuses, and immature postnatal individuals. It has called further attention to behavioral ability to learn or respond appropriately to a changing environment in the offspring that are prenatally exposed to various insults, even thoug...
متن کاملRediscovering Thalidomide
Thalidomide, a hypnosedative drug introduced in the 1950, has been used in a variety of dermatologic conditions during the past few decades. Although originally withbrawn from world market on discovery of its teratogenic effect, it has since been selectively reintroduced for use in various disorders thought to have an autoimmune or inflammatory basis. A review of the literature focused on clini...
متن کاملThe History and Implications of Testing Thalidomide on Animals
The current use of animals to test for potential teratogenic effects of drugs and other chemicals dates back to the thalidomide disaster of the late 1950s and early 1960s. Controversy surrounds the following questions: 1. What was known about placental transfer of drugs when thalidomide was developed? 2. Was thalidomide tested on animals for teratogenicity prior to its release? 3. Would more an...
متن کاملTeratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.
Thalidomide (a-[N-phthalmido]-glutarimide) was synthesized in 1954, in what was then West Germany, by Chemie Grünenthal under the brand name of Contergan and was subsequently licensed in 46 other countries worldwide, covering all continents. It is an odorless white crystalline compound with low solubility in water (McBride, ’77; Stirling et al., ’97). A number of pharmaceutical companies manufa...
متن کامل